| Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors MS Beg, AJ Brenner, J Sachdev, M Borad, YK Kang, J Stoudemire, ... Investigational new drugs 35, 180-188, 2017 | 793 | 2017 |
| Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours DS Hong, YK Kang, M Borad, J Sachdev, S Ejadi, HY Lim, AJ Brenner, ... British journal of cancer 122 (11), 1630-1637, 2020 | 555 | 2020 |
| First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma LM Liau, K Ashkan, DD Tran, JL Campian, JE Trusheim, CS Cobbs, ... Journal of translational medicine 16, 1-9, 2018 | 533 | 2018 |
| WWOX, the FRA16D gene, behaves as a suppressor of tumor growth AK Bednarek, CL Keck-Waggoner, RL Daniel, KJ Laflin, PL Bergsagel, ... Cancer research 61 (22), 8068-8073, 2001 | 439 | 2001 |
| Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation AJ Brenner, MR Stampfer, CM Aldaz Oncogene 17 (2), 199-205, 1998 | 365 | 1998 |
| A quantitative test for copper using bicinchoninic acid AJ Brenner, ED Harris Analytical biochemistry 226 (1), 80-84, 1995 | 261 | 1995 |
| The current state of molecular testing in the treatment of patients with solid tumors, 2019 WS El‐Deiry, RM Goldberg, HJ Lenz, AF Shields, GT Gibney, AR Tan, ... CA: a cancer journal for clinicians 69 (4), 305-343, 2019 | 247 | 2019 |
| Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors R Kurzrock, N Gabrail, C Chandhasin, S Moulder, C Smith, A Brenner, ... Molecular cancer therapeutics 11 (2), 308-316, 2012 | 192 | 2012 |
| Phase I study of GRN1005 in recurrent malignant glioma J Drappatz, A Brenner, ET Wong, A Eichler, D Schiff, MD Groves, ... Clinical Cancer Research 19 (6), 1567-1576, 2013 | 183 | 2013 |
| Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. AK Bednarek, A Sahin, AJ Brenner, DA Johnston, CM Aldaz Clinical cancer research: an official journal of the American Association …, 1997 | 174 | 1997 |
| Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 … LM Liau, K Ashkan, S Brem, JL Campian, JE Trusheim, FM Iwamoto, ... JAMA oncology 9 (1), 112-121, 2023 | 173 | 2023 |
| ANG1005, a brain-penetrating peptide–drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases P Kumthekar, SC Tang, AJ Brenner, S Kesari, DE Piccioni, C Anders, ... Clinical Cancer Research 26 (12), 2789-2799, 2020 | 163 | 2020 |
| Chromosome 9p Allelic Loss and p16/CDKN2 in Breast Cancer and Evidence of p16 Inactivation in Immortal Breast Epithelial Cells AJ Brenner, CM Aldaz Cancer research 55 (13), 2892-2895, 1995 | 152 | 1995 |
| First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors G Falchook, J Infante, HT Arkenau, MR Patel, E Dean, E Borazanci, ... EClinicalMedicine 34, 2021 | 128 | 2021 |
| Common toxicities of mammalian target of rapamycin inhibitors SA Soefje, A Karnad, AJ Brenner Targeted oncology 6, 125-129, 2011 | 122 | 2011 |
| Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma P Hau, D Koch, T Hundsberger, E Marg, B Bauer, R Rudolph, M Rauch, ... Neurology 68 (9), 688-690, 2007 | 116 | 2007 |
| Therapeutic significance of estrogen receptor β agonists in gliomas GR Sareddy, BC Nair, VK Gonugunta, Q Zhang, A Brenner, DW Brann, ... Molecular cancer therapeutics 11 (5), 1174-1182, 2012 | 112 | 2012 |
| NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin–aromatase interactions LW Bowers, IXF Maximo, AJ Brenner, M Beeram, SD Hursting, RS Price, ... Cancer research 74 (16), 4446-4457, 2014 | 109 | 2014 |
| Metabolomic signature of brain cancer R Pandey, L Caflisch, A Lodi, AJ Brenner, S Tiziani Molecular Carcinogenesis 56 (11), 2355-2371, 2017 | 108 | 2017 |
| Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles WT Phillips, A Bao, AJ Brenner, BA Goins Advanced Drug Delivery Reviews 76, 39-59, 2014 | 94 | 2014 |
Ratna VadlamudiUT Health Science Center San AntonioAdresse e-mail validée de uthscsa.edu
